Brain Metastasis Velocity (BMV) Model
ورودیهای بالینی بیمار
حداقل ۱ — حداکثر ۱۰۰ • واحد: metastases
حداقل ۰.۰۱ — حداکثر ۱۰ • واحد: years
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low BMV0–4
- Intermediate BMV4–13
- High BMV13–999
The Brain Metastasis Velocity (BMV) Model calculates calculating rate of distant brain failure after stereotactic radiosurgery for brain metastasis to predict overall survival. Key inputs include new metastases. Scores guide adjusting systemic antineoplastic regimens, planning supportive palliative measures, or targeted monitoring. Routine clinical application promotes standardized evidence-based patient management.
Clinical Guidelines & Evidence
Calculates rate of distant brain failure after stereotactic radiosurgery for brain metastasis to predict overall survival
Clinical Indication
The Brain Metastasis Velocity (BMV) Model is indicated for bedside clinical practice to support Calculates rate of distant brain failure after stereotactic radiosurgery for brain metastasis to predict overall survival. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients with solid tumors or hematologic malignancies undergoing staging, systemic therapy tolerability assessment, or prognostic stratification. Clinical application is indicated across Medical oncology clinics, chemotherapy infusion suites, inpatient oncology services, and palliative care.
Limitations & Contraindications
Prognostic indices provide statistical cohort survival estimates and must not replace individualized patient goals of care.
Clinical Pearls & Action Plan
Standardized functional performance status (ECOG or Karnofsky) is an independent determinant of chemotherapy tolerance and survival. Guideline pearl: Should not be the sole guide for treatment decisions - tumor histology and extracranial control should also be considered.
BMV = Number of new brain metastases / Time interval (years)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| new_metastases | integer | Yes | Number of new brain metastases since initial stereotactic radiosurgery (SRS)(metastases) |
| time_interval | float | Yes | Time interval between initial SRS and appearance of new brain metastases, in years(years) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–4 | Low BMV | Low brain metastasis velocity |
| 4–13 | Intermediate BMV | Intermediate brain metastasis velocity |
| 13–999 | High BMV | High brain metastasis velocity |
Evidence-Based References (EBM)
- Farris M, McTyre ER, Cramer CK, Hughes R, Randolph DM 2nd, Ayala-Peacock DN, et al. Brain Metastasis Velocity: A Novel Prognostic Metric Predictive of Overall Survival and Freedom From Whole-Brain Radiation Therapy After Distant Brain Failure Following Upfront Radiosurgery Alone. Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):131-141. doi: 10.1016/j.ijrobp.2017.01.201.DOI: 10.1016/j.ijrobp.2017.01.201
- Yamamoto M, Aiyama H, Koiso T, Watanabe S, Kawabe T, Sato Y, et al. Validity of a Recently Proposed Prognostic Grading Index, Brain Metastasis Velocity, for Patients With Brain Metastasis Undergoing Multiple Radiosurgical Procedures. Int J Radiat Oncol Biol Phys. 2019 Mar 15;103(3):631-637. doi: 10.1016/j.ijrobp.2018.10.036.DOI: 10.1016/j.ijrobp.2018.10.036